Literature DB >> 26526220

Non-allergic asthma as a CFTR-related disorder.

Angela Schulz1, Burkhard Tümmler2.   

Abstract

BACKGROUND: CFTR dysfunction can be involved in CBAVD, pancreatitis or bronchiectasis.
METHODS: Subjects with cystic fibrosis-like disease, equivocal sweat chloride concentrations and no or one disease-causing CFTR mutation were investigated by intestinal current and/or nasal potential difference measurements.
RESULTS: A subgroup of female patients who had been diagnosed to suffer from non-allergic asthma showed intermediary chloride concentrations in sweat test, normal chloride secretory responses in the intestine and an abnormal nasal potential difference with Sermet scores in the cystic fibrosis range.
CONCLUSION: Non-allergic asthma is a clinical entity that may be associated with CFTR dysfunction of the respiratory epithelium.
Copyright © 2015 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Asthma; Bronchiectasis; CFTR; Intestinal current measurement; Nasal transepithelial potential difference

Mesh:

Substances:

Year:  2015        PMID: 26526220     DOI: 10.1016/j.jcf.2015.10.011

Source DB:  PubMed          Journal:  J Cyst Fibros        ISSN: 1569-1993            Impact factor:   5.482


  8 in total

Review 1.  The therapeutic potential of CFTR modulators for COPD and other airway diseases.

Authors:  George M Solomon; Lianwu Fu; Steven M Rowe; James F Collawn
Journal:  Curr Opin Pharmacol       Date:  2017-11-10       Impact factor: 5.547

2.  Standardized Measurement of Nasal Membrane Transepithelial Potential Difference (NPD).

Authors:  George M Solomon; Inez Bronsveld; Kathryn Hayes; Michael Wilschanski; Paola Melotti; Steven M Rowe; Isabelle Sermet-Gaudelus
Journal:  J Vis Exp       Date:  2018-09-13       Impact factor: 1.355

Review 3.  Epithelial Anion Transport as Modulator of Chemokine Signaling.

Authors:  Andrea Schnúr; Péter Hegyi; Simon Rousseau; Gergely L Lukacs; Guido Veit
Journal:  Mediators Inflamm       Date:  2016-06-12       Impact factor: 4.711

4.  Adherence of Pseudomonas aeruginosa to cystic fibrosis buccal epithelial cells.

Authors:  Meike Lingner; Susanne Herrmann; Burkhard Tümmler
Journal:  ERJ Open Res       Date:  2017-01-17

Review 5.  Congenital Bilateral Absence of the Vas Deferens.

Authors:  Zhonglin Cai; Hongjun Li
Journal:  Front Genet       Date:  2022-02-11       Impact factor: 4.599

6.  The molecular evolution of function in the CFTR chloride channel.

Authors:  Daniel T Infield; Kerry M Strickland; Amit Gaggar; Nael A McCarty
Journal:  J Gen Physiol       Date:  2021-10-14       Impact factor: 4.000

7.  Therapeutic CFTR Correction Normalizes Systemic and Lung-Specific S1P Level Alterations Associated with Heart Failure.

Authors:  Franziska E Uhl; Lotte Vanherle; Frank Matthes; Anja Meissner
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

Review 8.  CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways.

Authors:  Sheylan D Patel; Taylor R Bono; Steven M Rowe; George M Solomon
Journal:  Eur Respir Rev       Date:  2020-06-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.